EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients

Muhammad Wasif Saif iD, Wen-Han Chang, Scott Myers, Michael Potts, Sanjive Qazi, Vuong Trieu iD

International Journal of Molecular Sciences · 01.07.2025 · 26 (13) · 6357

DOI: 10.3390/ijms26136357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.07.2025. Verfasst von Muhammad Wasif Saif und 5 weiteren Autor:innen. Beteiligte Einrichtung: Karmanos Cancer Institute, 4100 John R Street, HW04HO, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: Transforming Growth Factor beta2, Carcinoma, Pancreatic Ductal, DNA Methylation, Pancreatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oncotelic Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transforming growth factor-beta (TGF-β) exhibits dual roles in pancreatic ductal adenocarcinoma (PDAC), acting as a tumor suppressor in early stages and a tumor promoter in later disease. Among the three isoforms, TGFB2 is particularly associated with poor prognosis and aggressive phenotypes. This study evaluated the prognostic significance of TGFB2 mRNA and methylation levels in PDAC, with an emphasis on age-dependent effects. Bioinformatic analyses revealed that high TGFB2 expression was significantly associated with reduced overall survival (OS) in patients under 65 (TGFB2 high vs. low median OS: 17.9 vs. 66.9 months) but not in older cohorts. IL6 expression, a downstream target of TGF-β, followed a similar survival profile. Moreover, elevated TGFB2 methylation showed improved survival in younger patients (high methylation vs. low methylation median OS: 66.9 vs. 17.9 months). In addition, our clinical data from a PDAC trial using OT-101, an antisense oligonucleotide targeting TGFB2, further supported these findings—young patients treated with OT-101 showed improved OS compared to untreated controls. Notably, the methylation of TGFB1 also correlated with better OS in young patients. These results demonstrate the importance of TGFB2 as both a prognostic biomarker and therapeutic target in younger PDAC patients and further suggest that epigenetic modulation plays a key role in TGF-β signaling in pancreatic cancer progression. Our study emphasizes the isoform- and age-specific prognostic significance of TGFB2 in PDAC and supports the potential insights provided through methylation and expression profiling for personalized treatment strategies, particularly for younger patients who may benefit most from TGFB2-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta2Carcinoma, Pancreatic DuctalDNA MethylationPancreatic NeoplasmsHumansFemaleMalePrognosisMiddle AgedGene Expression Regulation, NeoplasticAgedBiomarkers, TumorAdultTransforming Growth Factor beta1Promoter Regions, Genetic

Stichwörter der Autor:innen

IL6OT-101PDACTGF-βTGFB2methylationpancreatic cancertrabedersen

Substanzen

Transforming Growth Factor beta2TGFB2 protein, humanBiomarkers, TumorTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Karmanos Cancer Institute, 4100 John R Street, HW04HO, Detroit, MI 48201, USA.
  • Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA.

ORCID-Profile: Muhammad Wasif Saif, Vuong Trieu

Förderung

  • Oncotelic Therapeutics

Zitieren

APA

Saif, M. W., Chang, W. H., Myers, S., Potts, M., Qazi, S., & Trieu, V. (2025). TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients. International Journal of Molecular Sciences, 26(13), 6357. https://doi.org/10.3390/ijms26136357

Vancouver

Saif MW, Chang WH, Myers S, Potts M, Qazi S, Trieu V. TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients. International Journal of Molecular Sciences. 2025;26(13):6357. doi:10.3390/ijms26136357

BibTeX
@article{Saif2025,
  author = {Saif, Muhammad Wasif and Chang, Wen-Han and Myers, Scott and Potts, Michael and Qazi, Sanjive and Trieu, Vuong},
  title = {TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {6357},
  doi = {10.3390/ijms26136357}
}
Kostenlos starten →